Friday, June 19, 2026

pharma · COVID-19 · Cystic Fibrosis · ARCT

Arcturus Therapeutics

Arcturus Therapeutics clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

10285 Science Center Dr, San Diego, California 92121, US HQ
2013 Founded
157 Employees
Public company Type
ARCT · NYSE Ticker
Company details
Status
Public
HQ
10285 Science Center Dr, San Diego, California 92121, US
Founded
2013
Employees
157
Programs
13
Drugs
7
Patents
55
Intelligence · Clinical Programs

Arcturus Therapeutics projects

2 ClinicalTrials.gov programs sponsored by Arcturus Therapeutics.

Arcturus Therapeutics has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ARCT-2138

    Arcturus Therapeutics Holdings

    Influenza, Human

    phase 1 mab completed

    1 trial
  2. ARCT-2304

    Arcturus Therapeutics Holdings

    Influenza, Human

    phase 1 mab completed

    1 trial

Frequently asked questions

How many clinical projects does Arcturus Therapeutics have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.